Quarterly report · Q1
4480.TEDINET S100QQKT
Period2023-01-01 → 2023-03-31
Filed2023-05-15
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥4.4bn | 2023-01-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥14.2bn | 2022-01-01 → 2022-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.9bn | 2022-01-01 → 2022-03-31 | Cons. | Net sales |
| Operating income | ¥380m | 2023-01-01 → 2023-03-31 | Cons. | Operating income |
| Operating income | −¥56m | 2022-01-01 → 2022-03-31 | Cons. | Operating income |
| Ordinary income | ¥503m | 2023-01-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.5bn | 2022-01-01 → 2022-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥26m | 2022-01-01 → 2022-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥550m | 2023-01-01 → 2023-03-31 | Cons. | Income before income taxes |
| Profit before tax | −¥26m | 2022-01-01 → 2022-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥358m | 2023-01-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.0bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥30m | 2022-01-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥381m | 2023-01-01 → 2023-03-31 | Cons. | Profit loss |
| Net income | −¥31m | 2022-01-01 → 2022-03-31 | Cons. | Profit loss |
| Total assets | ¥21.8bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥21.8bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥19.5bn | at 2022-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥6.2bn | at 2023-03-31 | Cons. | Liabilities |
| Total liabilities | ¥6.6bn | at 2022-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥15.6bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥15.2bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥13.8bn | at 2022-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥14.0bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥14.4bn | at 2022-12-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥11.15 | 2023-01-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥31.77 | 2022-01-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-0.95 | 2022-01-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥10.97 | 2023-01-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥31.16 | 2022-01-01 → 2022-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 70.9% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 69.1% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.3% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-01-01 → 2023-03-31 | ¥0 |
| Reconciling Itemsreconciling | revenue intersegment | 2023-01-01 → 2023-03-31 | ¥0 |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-03-31 | −¥573m |
| jpcrp040300-q1r_E33586-000Medical Platform Businessreportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥1.4bn |
| jpcrp040300-q1r_E33586-000Medical Platform Businessreportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥1.4bn |
| jpcrp040300-q1r_E33586-000Medical Platform Businessreportable segment | segment profit | 2023-01-01 → 2023-03-31 | ¥32m |
| jpcrp040300-q1r_E33586-000New Business Development Servicesreportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥88m |
| jpcrp040300-q1r_E33586-000New Business Development Servicesreportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥88m |
| jpcrp040300-q1r_E33586-000New Business Development Servicesreportable segment | segment profit | 2023-01-01 → 2023-03-31 | −¥44m |
| jpcrp040300-q1r_E33586-000Recruitment Platform Businessreportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥2.9bn |
| jpcrp040300-q1r_E33586-000Recruitment Platform Businessreportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥2.9bn |
| jpcrp040300-q1r_E33586-000Recruitment Platform Businessreportable segment | revenue intersegment | 2023-01-01 → 2023-03-31 | ¥0 |
| jpcrp040300-q1r_E33586-000Recruitment Platform Businessreportable segment | segment profit | 2023-01-01 → 2023-03-31 | ¥965m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-01-01 → 2023-03-31 | ¥4.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-01-01 → 2023-03-31 | ¥4.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-01-01 → 2023-03-31 | ¥0 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-01-01 → 2023-03-31 | ¥954m |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-03-31 | −¥493m |
| jpcrp040300-q1r_E33586-000Medical Platform Businessreportable segment | revenue | 2022-01-01 → 2022-03-31 | ¥790m |
| jpcrp040300-q1r_E33586-000Medical Platform Businessreportable segment | revenue external | 2022-01-01 → 2022-03-31 | ¥790m |
| jpcrp040300-q1r_E33586-000Medical Platform Businessreportable segment | segment profit | 2022-01-01 → 2022-03-31 | −¥101m |
| jpcrp040300-q1r_E33586-000New Business Development Servicesreportable segment | revenue | 2022-01-01 → 2022-03-31 | ¥73m |
| jpcrp040300-q1r_E33586-000New Business Development Servicesreportable segment | revenue external | 2022-01-01 → 2022-03-31 | ¥73m |
| jpcrp040300-q1r_E33586-000New Business Development Servicesreportable segment | segment profit | 2022-01-01 → 2022-03-31 | −¥16m |
| jpcrp040300-q1r_E33586-000Recruitment Platform Businessreportable segment | revenue | 2022-01-01 → 2022-03-31 | ¥2.0bn |
| jpcrp040300-q1r_E33586-000Recruitment Platform Businessreportable segment | revenue external | 2022-01-01 → 2022-03-31 | ¥2.0bn |
| jpcrp040300-q1r_E33586-000Recruitment Platform Businessreportable segment | segment profit | 2022-01-01 → 2022-03-31 | ¥554m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-01-01 → 2022-03-31 | ¥2.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-01-01 → 2022-03-31 | ¥2.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-01-01 → 2022-03-31 | ¥436m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 351
| Item | Context | Value | Unit |
|---|---|---|---|
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |